Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic lymphocytic leukemia.

K R Rai, A Sawitsky, K Jagathambal

    The Medical Clinics of North America
    |May 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Portable Home-Use Triglyceride Meter Demonstrates Good Agreement With Plasma Laboratory Measures During Pregnancies Complicated by Metabolic Disease.

    Endocrinology, diabetes & metabolism·2026
    Same author

    Development and validation of a cephalosporin allergy clinical decision rule.

    The Journal of infection·2025
    Same author

    Spectrum of offending drugs and cutaneous adverse drug reactions requiring hospitalisation in a tertiary South African hospital in TB/HIV endemic setting.

    Frontiers in allergy·2024
    Same author

    Automatic classification of ICA components from infant EEG using MARA.

    Developmental cognitive neuroscience·2021
    Same author

    Interpersonal Neural Entrainment during Early Social Interaction.

    Trends in cognitive sciences·2020
    Same author

    D-2-hydroxyglutaric aciduria in a patient with speech delay due to a novel homozygous deletion in the <i>D2HGDH</i> gene.

    Molecular genetics and metabolism reports·2019
    Same journal

    Care Transitions Continue to Evolve.

    The Medical clinics of North America·2026
    Same journal

    Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

    The Medical clinics of North America·2026
    Same journal

    Care Transitions and Value-Based Payment Models in the United States.

    The Medical clinics of North America·2026
    Same journal

    Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

    The Medical clinics of North America·2026
    Same journal

    Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

    The Medical clinics of North America·2026
    Same journal

    Social Determinants of Health: Unique Considerations in Transitions of Care.

    The Medical clinics of North America·2026
    See all related articles

    This review covers recent breakthroughs in chronic lymphocytic leukemia (CLL) immunology and clinical features. It details current treatment strategies based on clinical staging and anticipates future diagnostic and therapeutic advancements.

    Area of Science:

    • Hematology
    • Oncology
    • Immunology

    Background:

    • Chronic lymphocytic leukemia (CLL) is a common B-cell malignancy.
    • Understanding CLL immunology and clinical presentation is crucial for effective management.

    Purpose of the Study:

    • To review recent advances in CLL immunology and clinical characteristics.
    • To detail current treatment methods based on clinical staging.
    • To outline future directions in CLL investigation and therapy.

    Main Methods:

    • Literature review of recent advances in CLL.
    • Description of treatment protocols based on clinical staging.
    • Expert opinion on future trends in CLL management.

    Main Results:

    Related Experiment Videos

    • Recent progress in understanding CLL immunobiology.
    • Current clinical staging impacts treatment decisions.
    • Anticipated developments in diagnostic and therapeutic approaches.

    Conclusions:

    • Advances in CLL understanding necessitate updated clinical approaches.
    • Personalized treatment strategies are evolving.
    • Future research will likely focus on novel immunotherapies and targeted agents.